Core Laboratories Inc. (NYSE:CLB) Shares Purchased by Squarepoint Ops LLC

Squarepoint Ops LLC grew its position in shares of Core Laboratories Inc. (NYSE:CLB - Free Report) by 91.5% in the 4th quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 111,305 shares of the oil and gas company's stock after acquiring an additional 53,188 shares during the quarter. Squarepoint Ops LLC owned about 0.24% of Core Laboratories worth $1,927,000 as of its most recent filing with the SEC.

Other institutional investors have also modified their holdings of the company. Two Sigma Investments LP lifted its position in Core Laboratories by 11.9% in the 4th quarter. Two Sigma Investments LP now owns 84,277 shares of the oil and gas company's stock valued at $1,459,000 after purchasing an additional 8,957 shares during the last quarter. Tidal Investments LLC raised its holdings in shares of Core Laboratories by 13.1% during the fourth quarter. Tidal Investments LLC now owns 49,587 shares of the oil and gas company's stock valued at $858,000 after buying an additional 5,725 shares during the last quarter. Sherbrooke Park Advisers LLC bought a new stake in shares of Core Laboratories during the fourth quarter valued at approximately $176,000. Raiffeisen Bank International AG acquired a new position in shares of Core Laboratories during the fourth quarter worth approximately $1,706,000. Finally, Point72 Asset Management L.P. bought a new position in Core Laboratories in the 4th quarter worth approximately $266,000. Institutional investors own 97.81% of the company's stock.

Analyst Upgrades and Downgrades

Several brokerages have weighed in on CLB. Citigroup cut their target price on Core Laboratories from $16.00 to $13.00 and set a "neutral" rating on the stock in a research note on Tuesday, May 13th. Wall Street Zen cut shares of Core Laboratories from a "hold" rating to a "sell" rating in a research note on Friday, April 25th. Finally, Stifel Nicolaus reduced their price objective on shares of Core Laboratories from $19.00 to $15.00 and set a "hold" rating for the company in a report on Tuesday, April 15th. Two equities research analysts have rated the stock with a sell rating and three have assigned a hold rating to the company's stock. According to MarketBeat.com, the stock has an average rating of "Hold" and an average target price of $15.00.

Core Laboratories Price Performance

CLB traded down $0.14 during trading on Monday, reaching $10.62. The stock had a trading volume of 324,680 shares, compared to its average volume of 405,224. The stock has a 50 day moving average of $12.08 and a two-hundred day moving average of $15.73. The company has a quick ratio of 1.71, a current ratio of 2.32 and a debt-to-equity ratio of 0.49. The firm has a market capitalization of $497.66 million, a price-to-earnings ratio of 16.08, a price-to-earnings-growth ratio of 0.99 and a beta of 1.45. Core Laboratories Inc. has a 1-year low of $10.14 and a 1-year high of $25.13.

Core Laboratories (NYSE:CLB - Get Free Report) last posted its quarterly earnings data on Wednesday, April 23rd. The oil and gas company reported $0.14 EPS for the quarter, missing analysts' consensus estimates of $0.15 by ($0.01). Core Laboratories had a return on equity of 16.24% and a net margin of 5.99%. The firm had revenue of $123.59 million during the quarter, compared to the consensus estimate of $125.09 million. During the same period in the prior year, the firm posted $0.19 EPS. The firm's quarterly revenue was down 4.7% on a year-over-year basis. As a group, equities analysts anticipate that Core Laboratories Inc. will post 0.96 EPS for the current fiscal year.

Core Laboratories Announces Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Tuesday, May 27th. Stockholders of record on Monday, May 5th were given a dividend of $0.01 per share. The ex-dividend date of this dividend was Monday, May 5th. This represents a $0.04 annualized dividend and a dividend yield of 0.38%. Core Laboratories's dividend payout ratio (DPR) is 6.78%.

Core Laboratories Company Profile

Core Laboratories Inc provides reservoir description and production enhancement services and products to the oil and gas industry in the United States, and internationally. It operates through Reservoir Description and Production Enhancement segments. The Reservoir Description segment includes the characterization of petroleum reservoir rock and reservoir fluid samples to enhance production and improve recovery of crude oil and gas from its clients' reservoirs.